Algert Global LLC Invests $1.76 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Algert Global LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,015 shares of the healthcare conglomerate’s stock, valued at approximately $1,763,000.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at $27,000. Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the period. Macroview Investment Management LLC lifted its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the period. West Financial Advisors LLC bought a new stake in UnitedHealth Group during the third quarter valued at approximately $32,000. Finally, Bbjs Financial Advisors LLC bought a new position in UnitedHealth Group in the second quarter worth approximately $31,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

NYSE:UNH opened at $608.38 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company has a 50-day moving average of $584.09 and a 200 day moving average of $555.02. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market cap of $559.88 billion, a PE ratio of 39.63, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. During the same period in the prior year, the business posted $6.56 EPS. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on UNH shares. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. TD Cowen boosted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Finally, UBS Group cut their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $618.26.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.